SCHEMBL30456850

SCHEMBL30456850

CC(C)C(OOC(C)(C)CC(C)(C)C)OC(=O)O

nearest known ligand 0.30

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.30
MMP2 P08253 1/20 0.30
MMP3 P08254 1/20 0.30
MMP9 P14780 1/20 0.30
MMP13 P45452 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30457550 0.84
SCHEMBL30457146 0.81
SCHEMBL1260799 0.80
SCHEMBL30456990 0.79 LMNA (0.31)
SCHEMBL7691669 0.75
SCHEMBL3383209 0.73
SCHEMBL11559369 0.69
SCHEMBL28026907 0.68
SCHEMBL28733237 0.68 MMP1 (0.33) MMP1MMP2MMP3MMP9MMP13
SCHEMBL3382409 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4692177-A1 RESIN POWDER AND METHOD FOR PRODUCING SAME Kaneka Corporation (JP) 2026-02-11 EP disclosed
US-20250388748-A1 THERMOPLASTIC RESIN COMPOSITION KANEKA CORPORATION (JP) 2025-12-25 US disclosed
EP-4610313-A1 THERMOPLASTIC RESIN COMPOSITION Kaneka Corporation (JP) 2025-09-03 EP disclosed
US-20250250435-A1 THERMOPLASTIC RESIN COMPOSITION KANEKA CORPORATION (JP) 2025-08-07 US disclosed
US-20250243321-A1 METHOD FOR PRODUCING MODIFIED ALIPHATIC OR ALIPHATIC-AROMATIC THERMOPLASTIC POLYESTER RESIN KANEKA CORPORATION (JP) 2025-07-31 US disclosed
US-20250230273-A1 CROSSLINKED RESIN PARTICLES AND METHOD FOR PRODUCING THE SAME KANEKA CORPORATION (JP) 2025-07-17 US disclosed
US-20250215215-A1 THERMOPLASTIC RESIN COMPOSITION KANEKA CORPORATION (JP) 2025-07-03 US disclosed
US-20250066538-A1 MODIFIED ALIPHATIC POLYESTER RESIN AND COMPOSITION OR MOLDED ARTICLE THEREOF KANEKA CORPORATION (JP) 2025-02-27 US disclosed
EP-4506395-A1 CROSSLINKED RESIN PARTICLES AND METHOD FOR PRODUCING SAME Kaneka Corporation (JP) 2025-02-12 EP disclosed
EP-4502082-A1 THERMOPLASTIC RESIN COMPOSITION Kaneka Corporation (JP) 2025-02-05 EP disclosed
CN-118974177-A Thermoplastic resin composition 株式会社钟化 2024-11-15 CN disclosed
CN-118922477-A Crosslinked resin particle and method for producing same 株式会社钟化 2024-11-08 CN disclosed
CN-115803381-B Aliphatic polyester resin composition and use thereof 株式会社钟化 2024-09-24 CN disclosed
CN-118556095-A Modified aliphatic polyester resin, and composition or molded article thereof 株式会社钟化 2024-08-27 CN disclosed
CN-118541412-A Process for producing modified aliphatic or aliphatic aromatic thermoplastic polyester resin 株式会社钟化 2024-08-23 CN disclosed
US-20230323114-A1 ALIPHATIC-POLYESTER-BASED RESIN COMPOSITION AND UTILIZATION THEREOF KANEKA CORPORATION (JP) 2023-10-12 US disclosed
WO-2023190184-A1 THERMOPLASTIC RESIN COMPOSITION 株式会社カネカ 2023-10-05 WO disclosed
WO-2023190183-A1 CROSSLINKED RESIN PARTICLES AND METHOD FOR PRODUCING SAME 株式会社カネカ 2023-10-05 WO disclosed
WO-2023190185-A1 THERMOPLASTIC RESIN COMPOSITION 株式会社カネカ 2023-10-05 WO disclosed
EP-4183828-A1 ALIPHATIC-POLYESTER-BASED RESIN COMPOSITION AND UTILIZATION THEREOF Kaneka Corporation (JP) 2023-05-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250388748-A1 THERMOPLASTIC RESIN COMPOSITION HSPA4L, HSP90AA1, HACD3 MMP1 2502/4885MMP2 1924/4885MMP3 1445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.